Triptorelin

TrelstarSexual Health

Evidence grade

AFDA-approved Rx (labeled use)

Cardiovascular · 0–5 · separate axis

Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeReproductive axis

MechanismGnRH agonist producing sustained gonadotropin suppression after an initial flare

EffectsSame mechanism as leuprolide with a different depot profile

Dosing3.75 mg IM monthly; longer-acting depots per prescribing information

Bottom lineStrongest data when used for its labeled indication under clinician guidance.

Batches on filenone

No tested batches on file.

Read with10

Oxytocin Melanotan II Semaglutide Tirzepatide Liraglutide Exenatide Dulaglutide Pramlintide Cagrilintide Retatrutide

Cautions & interactions

Initial hormone flare; bone-density loss; hot flushes; injection-site reactions

Additive with other hormone therapies; may prolong QT.

CV 2 of 5 — Androgen deprivation carries recognised cardiometabolic risk over time.